Product image of Librax (Chlordiazepoxide, Clidinium Bromide) supplied by GNH India

Librax

Active Ingredient:
Chlordiazepoxide, Clidinium Bromide
Origin:
EU

Librax (Chlordiazepoxide, Clidinium Bromide)

Chlordiazepoxide, the active ingredient in Librax, is a benzodiazepine presented as an oral tablet for oral use. Together with the anticholinergic clidinium bromide, the combination treats anxiety and reduces gastrointestinal spasm in adult patients.

GNH India supplies Librax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Manufacturer / TM Owner

Viatris Aps

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Librax combines a benzodiazepine and an anticholinergic to address disorders of the central nervous system and the gastrointestinal tract.

  • Anxiety disorders: reduces excessive nervousness and tension in adult patients.
  • Irritable bowel syndrome: alleviates abdominal cramping and discomfort.
  • Peptic ulcer disease: diminishes ulcer‑related pain by relaxing gastric musculature.
  • Gastrointestinal spasm: lessens spasmodic contractions and associated pain.

How It Works

  • Chlordiazepoxide binds to the benzodiazepine site on the GABA‑A receptor complex, enhancing GABA‑induced chloride influx and producing anxiolytic, sedative and muscle‑relaxant effects. Clidinium bromide acts as a competitive antagonist at muscarinic acetylcholine receptors in the gastrointestinal smooth muscle, decreasing acetylcholine‑mediated contractions and secretions, thereby reducing spasm and associated pain.

Side Effects

Librax may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects

  • Drowsiness: feeling of sleepiness or reduced alertness.
  • Dry mouth: decreased salivation causing a dry oral cavity.
  • Constipation: slowed intestinal transit leading to hard stools.
  • Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects

  • Respiratory depression: slowed breathing that may require medical attention.
  • Severe hypotension: marked drop in blood pressure causing dizziness or fainting.
  • Paradoxical agitation: unexpected increase in anxiety or restlessness.

Precautions & Warnings

Before prescribing Librax, consider the following precautions to ensure safe use.

  • Assess hepatic function: dose may need adjustment in patients with liver impairment.
  • Evaluate for dependence: benzodiazepine component can cause tolerance with prolonged use.
  • Monitor elderly patients: increased sensitivity to sedative effects and fall risk.
  • Avoid abrupt discontinuation: tapering is recommended to prevent withdrawal symptoms.
  • Contraindicated in acute narrow‑angle glaucoma: anticholinergic effect may worsen intra‑ocular pressure.
  • Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Avoid Interactions

Librax can interact with other medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Opioids: combined CNS depression may lead to respiratory failure.
  • Other benzodiazepines: additive sedative effects increase risk of profound drowsiness.
  • Anticholinergic agents: excessive anticholinergic load can cause severe dry mouth, urinary retention, and constipation.

Moderate Interactions (Monitor Closely)

  • Antidepressants (SSRIs, SNRIs): may enhance serotonergic activity and increase sedation.
  • Antihistamines: additive anticholinergic effects may exacerbate dry mouth and blurred vision.
  • Alcohol: concurrent use can intensify sedation and impair coordination.

Frequently Asked Questions

Librax is prescribed for adult patients who need relief from anxiety, irritable bowel syndrome, peptic ulcer disease and other gastrointestinal spasms. The combination of a benzodiazepine and an anticholinergic addresses both central nervous system anxiety and excessive gut motility.

Chlordiazepoxide binds to the benzodiazepine site on GABA‑A receptors, increasing the inhibitory effect of GABA. This enhances chloride ion flow into neurons, producing anxiolytic, sedative and muscle‑relaxant actions that help calm the patient and reduce tension.

The appropriate dose of Librax is determined by the prescribing clinician based on the individual’s medical condition, age, liver function and response to therapy. Patients should follow the exact dosage instructions provided by their healthcare professional.

Safety data for Librax in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing individuals.

To request Librax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Librax uniquely combines a benzodiazepine with an anticholinergic, offering simultaneous anxiety relief and gastrointestinal spasm control. Single‑agent benzodiazepines address anxiety but not gut symptoms, while pure anticholinergics lack anxiolytic effects. This dual action can simplify therapy for patients needing both indications.

Librax tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct light, and ensure the container is tightly closed to maintain potency.

Librax is taken orally as a tablet, usually with a glass of water. The exact timing (e.g., with meals or on an empty stomach) is directed by the prescribing physician based on the therapeutic goal and patient tolerance.

Serious risks include respiratory depression, severe hypotension and paradoxical agitation, especially when combined with other central nervous system depressants or in patients with compromised respiratory function. Prompt medical attention is required if these symptoms occur.

Librax is contraindicated in patients with acute narrow‑angle glaucoma, severe hepatic impairment, known hypersensitivity to either component, and in individuals taking other potent CNS depressants without close supervision. Clinicians should assess each patient’s medical history before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Chlordiazepoxide, Clidinium Bromide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT